The scaffold molecule CD2066 antagonized Notch signaling, promoted DNA damage and synergized with the CDK1 inhibitor Ro3306, showing at least partial dependence of its antiviability effects on Notch signaling and relative specificity of its action for the T-ALL context. Here, CDK1 is linked to acute lymphoblastic leukemia.